首页 | 本学科首页   官方微博 | 高级检索  
检索        

术前低剂量胺碘酮预防非体外循环冠状动脉旁路移植术后心房颤动
引用本文:方颖,张兆光,顾承雄,于洋.术前低剂量胺碘酮预防非体外循环冠状动脉旁路移植术后心房颤动[J].中华老年医学杂志,2009,28(6).
作者姓名:方颖  张兆光  顾承雄  于洋
作者单位:首都医科大学附属安贞医院心脏外科六病房,北京市,100029
摘    要:目的 前瞻性的评估术前低剂量胺碘酮预防非体外循环冠状动脉旁路移植术后心房纤颤(房颤)的安全性、耐受性和有效性. 方法 将200例择期行非体外循环冠状动脉旁路移植手术(OPCAB)治疗的冠状动脉粥样硬化性心脏病患者随机分成研究组和对照组.对照组100例,术前给予常规药物和安慰剂;研究组100例,术前给予常规药物和低剂量胺碘酮,术后两组均用常规药物.结果 研究组的房颤发生率(15%)、房颤时最大心室率(126.0±20.8)次/min,房颤持续时间(8.0±8.6)h均低于对照组的房颤发生率((41%),(χ2=16.766,P=0.000]、房颤时最大心室率((150.0±25.6)次/min,t=0.478,P=0.017]以及房颤持续时间(12.0±9.6)h,t=0.439,P=0.019].本实验结果 显示研究组药物不良反应的发生较对照组差异无统计学意义(P均0.05).结论 术前预防性应用低剂量胺碘酮能安全有效减少房颤发生率,缩短房颤持续时间,并能降低术后房颧最大心室率,减轻临床症状.

关 键 词:冠状动脉旁路移植术  非体外循环  心房颤动  抗心律失常药  胺碘酮

Study on preoperative low dose amiodarone administration for prevention of atrial fibrillation after off-pump coronary artery bypass grafting
FANG-Ying,ZHANG Zhao-guang,GU Cheng-xiong,YU Yang.Study on preoperative low dose amiodarone administration for prevention of atrial fibrillation after off-pump coronary artery bypass grafting[J].Chinese Journal of Geriatrics,2009,28(6).
Authors:FANG-Ying  ZHANG Zhao-guang  GU Cheng-xiong  YU Yang
Abstract:Objective To assess the safety, tolerability and efficacy of preoperative low dose intravenous amiodarone in the prevention of atrial fibrillation (AF) after off-pump coronary artery bypass grafting (OPCAB). Methods Two hundred patients with coronary atheroselerotic heart disease underwent selected OPCAB and were randomly divided into two groups: control group (100 cases) and experimental group (100 cases). Patients in control group were given conventional medicines and placebo, and patients in experimental group were treated with low dose intravenous amiodarone daily for 4 days before surgery. They were given conventional medicines after surgery. Results After the off-pump coronary artery bypass grafting, the incidence of AF, ventricular rate and the duration of AF in the experimental group were lower than those in control group 15% vs. 41%, χ2=16.766, P=0.000; (126.0±20.8) times/ min vs. (150.0±25.6) times/ min, t=0.478, P =0. 017; (8. 0±8. 6) h vs. (12.0±9.6) h, t=0. 439, P=0. 019]. No significant difference were found in the incidence of side effect between low close amiodarone group and the control group. Conclusions Prophylactic application of low dose intravenous arniodarone before off-pump coronary artery bypass grafting can safely and effectively reduce the postoperative ventricular rate and the incidence of AF, shorten the duration of AF, promote the rehabilitation and slightly improve the clinical symptoms.
Keywords:Coronary artery bypass off-pump  Atrial fibrillation  Anti-arrhythmia agents  Amiodarone
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号